ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Nutrition and Supplements
Whey cancer cachexia syndrome
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Will Brink" data-source="post: 146924" data-attributes="member: 2074"><p>More whey win: a new review focused on the potential value of whey in cancer cachexia syndrome. It should be noted that some sub fractions in whey may directly inhibited cancer cell metabolism which this review mentions in the abstract:</p><p>Review</p><p></p><p>Whey Protein in Cancer Therapy: A Narrative Review</p><p></p><p>Abstract</p><p></p><p>Cancer remains a public health challenge in the identification and development of ideal pharmacological therapies and dietary strategies. The use of whey protein as a dietary strategy is widespread in the field of oncology. The two types of whey protein, sweet or acid, result from several processing techniques and possess distinct protein subfraction compositions. Mechanistically, whey protein subfractions have specific anti-cancer effects. Alpha-lactalbumin, human α-lactalbumin made lethal to tumor cell, bovine α-lactalbumin made lethal to tumor cell, bovine serum albumin, and lactoferrin are whey protein subfractions with potential to hinder tumor pathways. Such effects, however, are principally supported by studies performed in vitro and/or in vivo. In clinical practice, whey protein intake-induced anti-cancer effects are indiscernible. However, whey protein supplementation represents a practical, feasible, and cost-effective approach to mitigate cancer cachexia syndrome. The usefulness of whey protein is evidenced by a greater leucine content and the potential to modulate IGF-1 concentrations representing important factors towards musculoskeletal hypertrophy. Further clinical trials are warranted and needed to establish the effects of whey protein supplementation as an adjuvant to cancer therapy.</p><p></p><p>Source:</p><p></p><p><a href="https://www.sciencedirect.com/science/article/abs/pii/S1043661819303147?fbclid=IwAR0sKA7hXM5N0FrdTOtu2yWwLzyNm-TPtTslQVvMi7TVoTg8Z5uW9WxdWG4" target="_blank">https://www.sciencedirect.com/science/article/abs/pii/S1043661819303147?fbclid=IwAR0sKA7hXM5N0FrdTOtu2yWwLzyNm-TPtTslQVvMi7TVoTg8Z5uW9WxdWG4</a></p><p></p><p>For Qs, see <a href="https://www.excelmale.com/forum/threads/whey-q-a.9959/" target="_blank">Whey Q&A.</a></p></blockquote><p></p>
[QUOTE="Will Brink, post: 146924, member: 2074"] More whey win: a new review focused on the potential value of whey in cancer cachexia syndrome. It should be noted that some sub fractions in whey may directly inhibited cancer cell metabolism which this review mentions in the abstract: Review Whey Protein in Cancer Therapy: A Narrative Review Abstract Cancer remains a public health challenge in the identification and development of ideal pharmacological therapies and dietary strategies. The use of whey protein as a dietary strategy is widespread in the field of oncology. The two types of whey protein, sweet or acid, result from several processing techniques and possess distinct protein subfraction compositions. Mechanistically, whey protein subfractions have specific anti-cancer effects. Alpha-lactalbumin, human α-lactalbumin made lethal to tumor cell, bovine α-lactalbumin made lethal to tumor cell, bovine serum albumin, and lactoferrin are whey protein subfractions with potential to hinder tumor pathways. Such effects, however, are principally supported by studies performed in vitro and/or in vivo. In clinical practice, whey protein intake-induced anti-cancer effects are indiscernible. However, whey protein supplementation represents a practical, feasible, and cost-effective approach to mitigate cancer cachexia syndrome. The usefulness of whey protein is evidenced by a greater leucine content and the potential to modulate IGF-1 concentrations representing important factors towards musculoskeletal hypertrophy. Further clinical trials are warranted and needed to establish the effects of whey protein supplementation as an adjuvant to cancer therapy. Source: [URL]https://www.sciencedirect.com/science/article/abs/pii/S1043661819303147?fbclid=IwAR0sKA7hXM5N0FrdTOtu2yWwLzyNm-TPtTslQVvMi7TVoTg8Z5uW9WxdWG4[/URL] For Qs, see [URL='https://www.excelmale.com/forum/threads/whey-q-a.9959/']Whey Q&A.[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Nutrition and Supplements
Whey cancer cachexia syndrome
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top